In contrast, in two studies (GDS2736 and GDS1209) almost all samples of stage 3 synovial sarcomas and myxoid liposarcomas uniformly express ctag1b/a whereas various differentiated liposarcomas do not show re-activation (Figure 1 and Table 1). This evidence concerns the gene CTAG1B and synovial sarcoma.